Pacifico National, Inc. dba AmEx Pharmacy recalls BEVACIZUMAB 1.25 mg/0.05 mL 31G MJ syringe Intravitreal Injection. This biologic product was repackaged by AmEx Pharmac…

Recall date

April 19, 2019

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-1271-2019

FDA classification

Class II

Brand / firm

Pacifico National, Inc. dba AmEx Pharmacy

Sold / distributed

Nationwide in the US

Why it was recalled

Defective Delivery System: difficult to express

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

BEVACIZUMAB 1.25 mg/0.05 mL 31G MJ syringe Intravitreal Injection. This biologic product was repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901 Lot:190212AB BUD:5/13/2019, Repackaged on 2/12/2019